Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Acquired Aplastic Anemia: early-phase trial registry

1 of 2 indexed Acquired Aplastic Anemia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Acquired Aplastic Anemia: 2 US clinical trials tracked, 1 recruiting.

Acquired Aplastic Anemia is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital of Philadelphia, running 2 of these trials.

Enrollment posture brief

Registry condition acquired-aplastic-anemia

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Acquired Aplastic Anemia (th…50%
Open-enrollment share among volume-matched conditions near Acquired Aplastic Anemia

Acquired Aplastic Anemia lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acquired Aplastic Anemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acquired Aplastic Anemia is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Acquired Aplastic Anemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CliniMACs Device
1 trials
Phase 2 Established Dose from prior study, NCT03810196 Device
1 trials
Phase 2 Maximum Tolerated Dose determined in Phase 1 Device
1 trials
Phase 1 Dose Level 3 Device
1 trials
Phase 1 Dose Level 2 Device
1 trials
Phase 1 Dose Level 1 Device
1 trials

US sites by state

Facility locations filed on Acquired Aplastic Anemia trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acquired Aplastic Anemia page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acquired Aplastic Anemia condition card totals 2 registered trials; most-linked intervention CliniMACs; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.